Bang Ting (邦亭)邦亭

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

从长白山白眉蝮蛇[Agkistrodonhalys(pallas)]冻干蛇毒中提取分离得到的血凝酶是一种在国家药监局注册认定的药品。该药品含有明胶-c141ee52等成分。

该药品关联的活性成分包括:明胶Ming Jiao。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:锦州奥鸿药业有限责任公司Chinese legal name: 锦州奥鸿药业有限责任公司。

您可以探索含有相同成分的其他药品:明胶-c141ee52成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 邦亭) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 明胶Ming Jiao.

Manufacturers recorded for this product: 锦州奥鸿药业有限责任公司Chinese legal name: 锦州奥鸿药业有限责任公司.

Explore other medicines containing the same ingredient: 明胶 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 邦亭Recorded Chinese name: 邦亭
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 1单位(KU)Recorded Chinese specification

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 锦州奥鸿药业有限责任公司Chinese legal name: 锦州奥鸿药业有限责任公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20041730

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20041730

Manufacturer

Chinese legal name: 锦州奥鸿药业有限责任公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20041730

生产企业

锦州奥鸿药业有限责任公司(国产)

适应症

本品可用于需减少流血或止血的各种医疗情况,如:外科、内科、妇产科、眼科、耳鼻喉科、口腔科等临床科室的出血及出血性疾病;也可用来预防出血,如手术前用药,可避免或减少手术部位及手术后出血。

用法用量

静注、肌注或皮下注射,也可局部用药。 一般出血:成人1-2单位;儿童0.3-0.5单位。紧急出血:立即静注0.25-0.5单位,同时肌肉注射1单位。 各类外科手术:术前一天晚肌注1单位,术前1小时肌注1单位,术前15分钟静注1单位,术后3天,每天肌注1单位; 咯血:每12小时皮F注射1单位,必要时,开始时冉加静注1单位,最好是加入10ml的0.9%氯化钠液中,混合注射; 异常出血:剂量加倍,间隔6小时肌注1单位,至出血完全停止。

不良反应

不良反应发生率较低,偶见过敏样反应。如出现此类情况,可按一般抗过敏处理方法,给予抗组胺药或/和糖皮质激素及对症治疗。

禁忌

1.虽无关于血栓的报道,为安全计,有血栓病史者禁用。
2.对本品或同类药品过敏者禁用。

注意事项

1.动脉、大静脉受损的出血,必须及时外科手术处理。
2.播散性血管内凝血(DIC)及血液病导致的出血不是白眉蛇毒血凝酶的适应症。
3.血中缺乏血小板或某些凝血因子(如:凝血酶原等)时白眉蛇毒血凝酶没有代偿作用,宜在补充血小板或缺乏的凝血因子、或输注新鲜血液的基础上应用白眉蛇毒血凝酶。
4.在原发性纤溶系统亢进(如:内分泌腺、癌症手术等)的情况下,白眉蛇毒血凝酶宜与抗血纤溶酶的药物联合应用。
5.使用期间应注意观察病人的出、凝血时间。

贮藏

密封,在凉暗处(避光并不超过20℃)保存。

规格

1单位(KU)

证据Evidence

  • 批准文号: 国药准字H20041730
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.